China Renaissance Holdings Valuation

Is 6RN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6RN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 6RN's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 6RN's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6RN?

Key metric: As 6RN is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 6RN. This is calculated by dividing 6RN's market cap by their current revenue.
What is 6RN's PS Ratio?
PS Ratio	2.6x
Sales	CN¥531.84m
Market Cap	CN¥1.40b

6RN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 6RN's PS Ratio compare to its peers?

The above table shows the PS ratio for 6RN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	12.7x
ADE Bitcoin Group	45.4x	n/a	€287.5m
EUX EUWAX	4.7x	n/a	€197.8m
LUS1 Lang & Schwarz	0.3x	n/a	€182.6m
BWB Baader Bank	0.5x	n/a	€201.0m
6RN China Renaissance Holdings	2.6x	n/a	€1.5b

Price-To-Sales vs Peers: 6RN is good value based on its Price-To-Sales Ratio (2.6x) compared to the peer average (12.7x).

Price to Sales Ratio vs Industry

How does 6RN's PS Ratio compare vs other companies in the DE Capital Markets Industry?

22 Companies	Price / Sales	Estimated Growth	Market Cap
MLP MLP	0.6x	2.3%	US$671.02m
MUX Mutares SE KGaA	0.09x	10.5%	US$507.75m
AR4 AURELIUS Equity Opportunities SE KGaA	0.2x	0.01%	US$500.05m
AR4 AURELIUS Equity Opportunities SE KGaA	0.1x	n/a	US$409.25m

22 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 6RN is good value based on its Price-To-Sales Ratio (2.6x) compared to the German Capital Markets industry average (2.8x).

Price to Sales Ratio vs Fair Ratio

What is 6RN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6RN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	2.6x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 6RN's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

ORIX

JP¥3.8t

Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.

OIX

JP¥20.40

1.0%

22.2%

Mutares SE KGaA

€484.6m

A private equity firm specializing in investments in secondary direct, special situations, bridge financing, recapitalization, distressed/vulture, management succession, reorganization, carve-outs, turnarounds, spin-offs and re-funding.

MUX

€22.40

1.1%

-29.3%

Merchants Bancorp

US$1.9b

Operates as the diversified bank holding company in the United States.

3KD

US$39.20

5.9%

31.5%